What is Farxiga, and how is it used for heart failure?
Farxiga is the brand name for dapagliflozin, a drug in the sodium-glucose cotransporter 2 (SGLT2) inhibitor class. In heart failure, Farxiga is used to treat certain patients with heart failure to improve outcomes such as reducing the risk of cardiovascular death and worsening heart failure events.
Which types of heart failure does Farxiga work for?
Use in heart failure depends on the specific heart failure type (for example, reduced versus preserved ejection fraction). The key point is that SGLT2 inhibitors like Farxiga are used in heart failure populations where evidence supports benefit, but the exact eligibility criteria come from the prescribing information and regulatory approvals.
How does Farxiga help the heart in heart failure?
Farxiga’s heart-failure benefits come from mechanisms linked to SGLT2 inhibition, including effects on fluid balance and metabolic/vascular pathways. Even though it began as a diabetes medication, the heart-failure effects are not the same as glucose-lowering alone.
What side effects are common or important for Farxiga in heart failure patients?
Patients and clinicians typically pay attention to risks that are common across the SGLT2 class. These can include genital infections, volume depletion/low blood pressure (especially in people also taking diuretics or other blood-pressure–lowering drugs), and other safety issues that require monitoring during treatment.
What should patients do about dosing, missed doses, or stopping Farxiga?
Heart-failure patients usually take Farxiga once daily as directed by their clinician. If Farxiga is temporarily stopped for illness, surgery, or other circumstances, the timing and restart plan should follow the prescriber’s guidance and the safety information for SGLT2 inhibitors.
Can Farxiga be used alongside standard heart failure therapies?
Yes. In practice, Farxiga is commonly used together with other heart failure treatments such as guideline-directed medications. The exact combination depends on the patient’s blood pressure, kidney function, comorbidities, and tolerability.
Is there patent or pricing information for Farxiga?
For updates on patents, exclusivity, and generic/biosimilar competition signals for Farxiga, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/